Literature DB >> 22053686

Gestational choriocarcinoma arising in a tubal ectopic pregnancy: case report.

F K Boynukalin1, Z Erol, A I Aral, I H Boyar.   

Abstract

OBJECTIVES: Gestational choriocarcinoma associated with ectopic pregnancy is an extremely rare event. Here we report one of these cases. CASE: A 38-year-old, gravida 4, parity 3, patient was admitted to the emergency room with the complaint of abdominal pain. Peritoneal irritation signs were present and serum hCG level was found to be greater than 15000 mUI/ml. Transvaginal ultrasound images were compatible with ruptured tubal ectopic pregnancy. Hemoperitoneum and ruptured tuba were found at laparatomy and a right salpingectomy was performed. The histopathological evaluation reported the lesion as primary tubal choriocarcinoma. The patient was referred to a tertiary care center for treatment and follow-up.
CONCLUSION: Adequate monitoring of beta-hCG titers and careful examinations of pathologic specimens are important to avoid misdiagnosis of ectopic gestational trophoblastic disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22053686

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Ectopic tubal choriocarcinoma: a rarity.

Authors:  Seema Mehrotra; Urmila Singh; Madhumati Goel; Shilpi Chauhan
Journal:  BMJ Case Rep       Date:  2012-11-11

2.  Gestational Tubal Choriocarcinoma Presenting as a Pregnancy of Unknown Location following Ovarian Induction.

Authors:  Lawrence Hsu Lin; Koji Fushida; Eliane Azeka Hase; Regina Schultz; Laysa Manatta Tenorio; Fabricia Andrea Rosa Madia; Evelin Aline Zanardo; Leslie Domenici Kulikowski; Rossana Pulcineli Vieira Francisco
Journal:  Case Rep Obstet Gynecol       Date:  2018-05-03

Review 3.  Tubal choriocarcinoma presented as ruptured ectopic pregnancy: a case report and review of the literature.

Authors:  Shengjie Xu; Xiaohong Song; Chengjuan Jin; Yanli Li
Journal:  World J Surg Oncol       Date:  2020-09-12       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.